Molecular Diagnostic Testing in Malignant Gliomas: A Practical Update on Predictive Markers
Open Access
- 1 January 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 67 (1) , 1-15
Abstract
Advances in understanding the molecular underpinnings of cancer and in molecular diagnostic technologies have changed the clinical practice of oncoloKeywords
This publication has 105 references indexed in Scilit:
- Survey of treatment recommendations for anaplastic oligodendrogliomaNeuro-Oncology, 2007
- High-throughput oncogene mutation profiling in human cancerNature Genetics, 2007
- Phase I Trial of Polifeprosan 20 With Carmustine Implant Plus Continuous Infusion of Intravenous O6-Benzylguanine in Adults With Recurrent Malignant Glioma: New Approaches to Brain Tumor Therapy CNS Consortium TrialJournal of Clinical Oncology, 2007
- Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular DomainPLOS Medicine, 2006
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaNew England Journal of Medicine, 2006
- 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatmentEuropean Journal of Cancer, 2006
- BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH)Nucleic Acids Research, 2006
- Erlotinib in Lung Cancer — Molecular and Clinical Predictors of OutcomeNew England Journal of Medicine, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004